17 - 21 November 2025
ChemAI Week
From Monday, November 17th until Friday, November 21st, the Amsterdam Chemistry Network (ACN), Amsterdam AI4Science, and TI-COAST, will host several interesting ChemAI satellite events, such as courses and webinars, on the topic of artificial intelligence and chemistry, culminating in the third ChemAI Symposium on the Friday afternoon. Additionally, the ChemAI week is followed by a Lorentz Center Workshop AI for Secure, Safe, and Sustainable Molecules and Materials (AI4S3M2) on 24 - 28 November 2025.
| ChemAI Weekday | What’s happening |
|---|---|
| Monday, 25 November | • 11:00 - 12:00 hr: From Contemporary Computational Chemistry to Future Methods of Application Research lecture by Robert Pollice in room SP C0.110. • 15:00 - 17:00 hr: Elements of Artificial Intelligence – a Crash Course on Machine Learning for Chemists hybrid meeting (zoom link) at Science Park Room H0.08 and online by Bernd Ensing and Robert Pollice |
| Tuesday, 26 November | • 15:00 - 16:00 hr: Harnessing Deep Learning for Drug Discovery: Challenges and Opportunities AI4Science/CSM seminar by Francesca Grisoni in Science Park 904, Room C4.174 or online (meeting link) |
| Wednesday, 27 November | • 14:00 - 15:00 hr: Machine Learning Acceleration of Electronic Structure Calculations Lecture by Hannes Jonsson in Science Park 906 room C0.110 • 15:00 - 16:30 hr: Unlocking Data in the Cambridge Structural Database for Functional Materials Innovation Online workshop by Dr. Andrew Peel of the Cambridge Crystallographic Data Centre (meeting link) |
| Thursday, 28 November | • 10:00 - 12:00 hr: Get Hands-On with Open Multi-Modal Foundational Models for Materials and Chemistry Online workshop by Dr. Seiji Takeda and Dr. Indra Priyadarsini of IBM Research (meeting link) |
| Friday, 29 November | • Lab tours at Science Park • ChemAI Symposium |
| Monday, 2 December | • 15:00 – 18:30 The Future of Pharma is Active Learning Online symposium hosted by Jakob Zeitler (Matterhorn Studio/UCL) with speakers from Novo Nordisk, Bayer, Merck, Exscientia, and more (further information). |
NEWS
news